Tarsus Pharmaceuticals, Inc. TARS Accrued compensation and employee benefits
Accrued compensation and employee benefits at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s accrued compensation and employee benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s accrued compensation and employee benefits?
- Tarsus Pharmaceuticals, Inc. (TARS) reported accrued compensation and employee benefits of -$9.25M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s accrued compensation and employee benefits changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s accrued compensation and employee benefits decreased by 57.0% year-over-year, from -$5.89M to -$9.25M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s accrued compensation and employee benefits?
- Over 2 years (2021 to 2023), Tarsus Pharmaceuticals, Inc.'s accrued compensation and employee benefits has grown at a 109.6% compound annual growth rate (CAGR), from $1.76M to $7.73M.